Literature DB >> 31902413

Vaccination of Adults in General Medical Practice.

Paul Hunter1, Sandra Adamson Fryhofer2, Peter G Szilagyi3.   

Abstract

In vaccinating adults, clinicians face 2 types of challenges: (1) staying current on recommendations for influenza, pneumococcal, hepatitis A and B, zoster, and other vaccines and (2) addressing systemic barriers to implementing practices that increase vaccination rates. Although adult immunization rates remain suboptimal, there has been much good news in adult vaccination recently. New high-dose and adjuvanted influenza vaccines help improve immune response and may reduce influenza complications in older adults. The new recombinant zoster vaccine offers significantly more efficacy against zoster outbreaks and postherpetic neuralgia than zoster vaccine live. Pertussis vaccine given during the third trimester of pregnancy may prevent between 50% and 90% of pertussis infections in infants. Shorter time for completion (1 vs 6 months) of new, adjuvanted hepatitis B vaccine may increase adherence. Clinicians can address systemic barriers to increasing vaccination rates in their clinics and health care systems by following the Centers for Disease Control and Prevention's Standards for Adult Immunization Practice. Clinicians can help increase vaccination rates by writing standing orders and by advocating for nurses or medical assistants to receive training and protected time for assessing and documenting vaccination histories and administration. Strong recommendations that presume acceptance of vaccination are effective with most patients. Communication techniques similar to motivational interviewing can help with vaccine-hesitant patients. Clinicians, as experts on providing preventive services, can educate community leaders about the benefits of immunization and can inform vaccine experts about challenges of implementing vaccination recommendations in clinical practice and strategies that can work to raise vaccination rates.
Copyright © 2019 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 31902413     DOI: 10.1016/j.mayocp.2019.02.024

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  5 in total

1.  Knowledge, attitudes, beliefs and barriers of healthcare professionals and adults ≥ 65 years about vaccine-preventable diseases in Spain: the ADult Vaccination drIverS and barriErs (ADVISE) study.

Authors:  Esther Redondo Margüello; Antoni Trilla; Ignacio L B Munguira; Almudena Jaramillo López-Herce; Manuel Cotarelo Suárez
Journal:  Hum Vaccin Immunother       Date:  2022-02-16       Impact factor: 3.452

2.  Clinical Efficacy of Pulsed Radiofrequency Combined with Intravenous Lidocaine Infusion in the Treatment of Subacute Herpes Zoster Neuralgia.

Authors:  Wanyun Zhang; Chunjing He
Journal:  Pain Res Manag       Date:  2022-04-11       Impact factor: 2.667

3.  Estimated Public Health Impact of the Recombinant Zoster Vaccine.

Authors:  Brandon J Patterson; Philip O Buck; Desmond Curran; Desirée Van Oorschot; Justin Carrico; William L Herring; Yuanhui Zhang; Jeffrey J Stoddard
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2021-05-26

4.  Patterns of recommended vaccine receipt among women ages 24-45 years: a cross-sectional analysis.

Authors:  Mallory K Ellingson; Carlos R Oliveira; Sangini S Sheth; Erin L Sullivan; Ashlynn Torres; Eugene D Shapiro; Linda M Niccolai
Journal:  BMC Public Health       Date:  2021-07-01       Impact factor: 3.295

5.  Cumulative annual coverage of meningococcal B vaccination in Australian general practice for three at-risk groups, 2014 to 2019.

Authors:  Juliana de Oliveira Costa; Christopher Gianacas; Frank Beard; David Gonzalez-Chica; Kendal Chidwick; Rawa Osman; C Raina MacIntyre; Alys Havard
Journal:  Hum Vaccin Immunother       Date:  2021-05-28       Impact factor: 4.526

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.